Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Indlægsklinikken.dk ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2017 2017/9 2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023e N/A 2024e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.7%   Bankruptcy risk   4.3% 2.8% 3.2% 3.1% 2.4% 2.0% 17.9% 16.6%   Credit score (0-100)   50 61 57 56 62 68 2 2   Credit rating   BBB BBB BBB BBB BBB A B BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2017 2017/9 2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023e N/A 2024e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   698 930 1,619 1,626 1,883 2,689 0.0 0.0   EBITDA   95.4 119 353 347 496 658 0.0 0.0   EBIT   94.5 117 308 288 412 560 0.0 0.0   Pre-tax profit (PTP)   93.0 112.6 305.5 280.6 408.0 557.4 0.0 0.0   Net earnings   72.8 92.1 236.3 214.6 320.4 434.6 0.0 0.0   Pre-tax profit without non-rec. items   93.0 113 305 281 408 557 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2017 2017/9 2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023e N/A 2024e N/A Tangible assets total   0.0 27.7 246 202 289 191 0.0 0.0   Shareholders equity total   182 337 464 428 549 863 304 304   Interest-bearing liabilities   40.2 50.7 1.0 1.0 1.0 1.0 0.0 0.0   Balance sheet total (assets)   439 700 930 1,186 1,238 1,631 304 304   Net Debt   -137 -173 -213 -510 -305 -562 -304 -304     See the entire balance sheet 1000.0 Volume  2017 2017/9 2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023e N/A 2024e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   698 930 1,619 1,626 1,883 2,689 0.0 0.0   Gross profit growth   -2.5% 33.2% 74.0% 0.4% 15.8% 42.8% -100.0% 0.0%   Employees   0 0 0 2 2 3 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 50.0% -100.0% 0.0%   Employee expenses   0.0 -811.4 -1,258.7 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   439 700 930 1,186 1,238 1,631 304 304   Balance sheet change%   21.3% 59.6% 32.9% 27.5% 4.4% 31.7% -81.3% 0.0%   Added value   94.5 928.7 1,566.8 287.6 412.1 559.7 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -2 26 173 -104 4 -196 -191 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   2.0 3.0 4.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2017 2017/9 2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023e N/A 2024e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   13.5% 12.6% 19.0% 17.7% 21.9% 20.8% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   23.6% 20.6% 37.8% 27.2% 34.0% 39.0% 0.0% 0.0%   ROI %   51.0% 38.4% 72.0% 63.7% 83.1% 78.8% 0.0% 0.0%   ROE %   49.8% 35.4% 59.0% 48.1% 65.6% 61.6% 0.0% 0.0%   1000.0 Solidity  2017 2017/9 2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023e N/A 2024e N/A Equity ratio %   48.3% 48.2% 49.8% 36.1% 44.3% 52.9% 100.0% 50.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -143.8% -145.8% -60.2% -146.8% -61.5% -85.5% 0.0% 0.0%   Gearing %   22.0% 15.0% 0.2% 0.2% 0.2% 0.1% 0.0% -100.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   4.0% 10.3% 10.5% 699.3% 404.6% 233.3% 0.0% 0.0%   1000.0 Liquidity  2017 2017/9 2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023e N/A 2024e N/A Quick Ratio   1.9 1.3 1.2 1.0 0.6 1.0 0.0 0.0   Current Ratio   1.7 1.5 1.4 1.3 1.2 1.9 0.0 0.0   Cash and cash equivalent   177.3 223.7 213.5 511.1 306.0 563.5 0.0 0.0   1000.0 Capital use efficiency  2017 2017/9 2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023e N/A 2024e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   175.0 182.1 168.3 171.5 139.7 579.5 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2017 2017/9 2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023e N/A 2024e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 144 206 187 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 174 248 219 0 0   EBIT / employee   0 0 0 144 206 187 0 0   Net earnings / employee   0 0 0 107 160 145 0 0